Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLCE1 antisense RNA 1 (PLCE1-AS1) is a long non-coding RNA (lncRNA) classified as an antisense transcript, divergent from the PLCE1 gene locus on chromosome 10 (chr10:94283161-94287478)[1][4]. PLCE1-AS1 does not code for a protein, as confirmed by multiple computational assessments[1]. As an antisense RNA, its main molecular functions involve regulation of gene expression post-transcriptionally and/or through epigenetic mechanisms, often in cis with respect to the PLCE1 gene. The general biological roles of antisense lncRNAs include modulation of nearby gene expression (commonly the sense gene from which they are transcribed, here likely affecting the PLCE1 gene) via diverse mechanisms such as transcriptional interference, chromatin modification, and RNA-RNA interactions[3][4]. No evidence currently classifies PLCE1-AS1 as a therapeutic target or as having established roles in specific diseases or drug interactions, and it is not recognized as a biomarker or associated with notable safety concerns[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLCE1 antisense RNA 1 (PLCE1-AS1).